Competitive intelligence on
small-molecule drugs and
the 90,000 global patents
|Title:||Methods and devices for treating plumonary vasoconstriction and asthma|
|Abstract:||A method for treating or preventing bronchoconstriction or reversible pulmonary vasoconstriction in a mammal, which method includes causing the mammal to inhale a therapeutically-effective concentration of gaseous nitric oxide or a therapeutically-effective amount of a nitric oxide-releasing compound, and an inhaler device containing nitric oxide gas and/or a nitric oxide-releasing compound.|
|Inventor(s):||Zapol; Warren M. (Concord, MA), Frostell; Claes (Danderyd, SE)|
|Assignee:||The General Hospital Corporation (Boston, MA)|
Patent Claim Types:|
see list of patent claims
|Use; Delivery; Device; Compound;|
|Country||Document Number||Publication Date|
|Spain||2132043||Aug 16, 1999|
|Canada||2186892||Oct 12, 1995|
|Australia||657726||Mar 23, 1995|
|Japan||2701978||Jan 21, 1998|
|Australia||9149891||Jul 08, 1992|
|This preview shows a limited data set|
Subscribe for full access, or try a free trial
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.